Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma. - Wikidata - awgldk - TriplyDB

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

http://www.wikidata.org/entity/Q39788214

about

Interleukin-6 Deficiency Attenuates Retinal Ganglion Cell Axonopathy and Glaucoma-Related Vision Loss.Erythropoietin Slows Photoreceptor Cell Death in a Mouse Model of Autosomal Dominant Retinitis Pigmentosa.Virus-mediated EpoR76E gene therapy preserves vision in a glaucoma model by modulating neuroinflammation and decreasing oxidative stress.Overexpression of Soluble Fas Ligand following Adeno-Associated Virus Gene Therapy Prevents Retinal Ganglion Cell Death in Chronic and Acute Murine Models of Glaucoma.Erythropoietin either Prevents or Exacerbates Retinal Damage from Eye Trauma Depending on Treatment Timing.Age-related Changes in Eye, Brain and Visuomotor Behavior in the DBA/2J Mouse Model of Chronic Glaucoma.Morphological and functional changes in the rat retina associated with 2 months of intermittent moderate intraocular pressure elevation.Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma Antioxidants prevent inflammation and preserve the optic projection and visual function in experimental neurotrauma Ccl5 Mediates Proper Wiring of Feedforward and Lateral Inhibition Pathways in the Inner Retina

P2860

Q33743591-83E3C0BC-F615-4165-87BC-F5A72B78DD10 Q36051639-DE5469CB-2CB5-48C5-B736-3DCAB1500276 Q38438082-31B025E6-6C33-4786-B81D-890A0ED41902 Q39184214-66927009-B56B-4FC9-9759-918DEC27A9BD Q40709924-C4FF0E9A-7DA3-4E1E-8588-B102FEEB62F9 Q52653208-327AE69C-5FB0-4E6B-A8E1-D36C9B94F771 Q55426245-11F6C88B-164D-4701-BE71-B25A0539DCA1 Q57039780-5C7F9932-5B9D-4FAE-AD1D-36333AF890DA Q58113183-A2A08545-5664-4AAF-B6A8-ED57EC0646AB Q58122628-AC1016ED-3925-44DB-B1A2-3E8534DA0490

P2860

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

http://www.wikidata.org/entity/Q39788214

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

@en

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

@nl

type

label

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

@en

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

@nl

prefLabel

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

@en

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma.

@nl

P1433

Q39788214-58EFAF84-363F-43CE-B6BF-6CC20E52A3FD

P1476

Q39788214-03BD0C2B-AF33-47E2-A6D9-B894F77C5AC3

P2093

Q39788214-0798C308-BA1B-405D-B35B-AA7DE3BFCB85

Q39788214-24421499-5DC0-4C27-BCE8-3F79F0D9FADE

Q39788214-4244D6A7-5039-418E-B462-EF4A3D17B675

Q39788214-570ED334-1684-42D5-9043-231AAE563E94

Q39788214-660C7876-5C14-4C7C-8375-CDAD726E2176

Q39788214-B675F9A7-36A9-4E3D-B50E-8E3A9EAEADB1

P2860

Q39788214-124DD4B4-DBA7-4C27-96B7-2ED7C352FB8D

Q39788214-1306FE8E-2BFE-442A-9054-D9EE05341708

Q39788214-138A5489-5123-44DC-A885-94EE766B8F0C

Q39788214-1B1B0E5D-ABDE-4238-AF6E-3034FBA0FCC2

Q39788214-2376ADC4-3D33-4B4D-821E-C4281EB4EEB1

Q39788214-242AFDFC-B9B3-44AE-B20F-09743C5DCB0D

Q39788214-3BB553F2-263F-4FB4-9F7C-F49547D94FB0

Q39788214-3F47D705-12B9-4841-A8A1-D5E6F76E246A

Q39788214-507E5CF5-687C-404E-B732-3F6E636E2A84

Q39788214-53F3106F-B44B-43A9-9AA7-7BD0212C35F2

P304

Q39788214-E2F164CE-D936-46EF-ADE9-FFC773901E92

P31

Q39788214-BA13F6B7-A5FC-47CC-90F7-7C4F6850112A

P356

Q39788214-1C7FF9E5-FB98-4198-B608-56CA04285FE3

P433

Q39788214-FEB3557B-ED62-4972-A71C-075CE15B646B

P478

Q39788214-C9A599DE-1C76-47D1-960C-77DA6C82D000

P50

Q39788214-393EFB9E-CE0B-449F-B2B5-CE5DFD3F7A4E

Q39788214-C4186AB3-BB8E-42A6-86BD-0460C8E4BB7E

P577

Q39788214-A0351C35-BEBD-4606-B0D1-A1F2DC3C2B91

P698

Q39788214-561AD1B5-3000-4D8E-BBD8-504A53BDDB7C

P932

Q39788214-CC7648AB-A523-43A6-BFE3-878D2CE050B6

P356

P1433

Molecular Therapy

P1476

Virus-mediated EpoR76E Therapy Slows Optic Nerve Axonopathy in Experimental Glaucoma

@en

P2093

Alma Farooque

http://www.w3.org/2001/XMLSchema#string

David J Calkins

http://www.w3.org/2001/XMLSchema#string

Jessica Hines-Beard

http://www.w3.org/2001/XMLSchema#string

Mara Davis

http://www.w3.org/2001/XMLSchema#string

Tonia S Rex

http://www.w3.org/2001/XMLSchema#string

Wesley S Bond

http://www.w3.org/2001/XMLSchema#string

P2860

Critical pathogenic events underlying progression of neurodegeneration in glaucoma

Oxidative stress and the regulation of complement activation in human glaucoma

Early microglia activation in a mouse model of chronic glaucoma.

Ganglion cell losses underlying visual field defects from experimental glaucoma.

Current management of glaucoma.

Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric

Distal axonopathy with structural persistence in glaucomatous neurodegeneration.

Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons

The microbead occlusion model: a paradigm for induced ocular hypertension in rats and mice.

High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma.

P304

230-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2015.198

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Rebecca M Sappington

YPaul L GoldenMerry

P577

2015-10-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26502777

http://www.w3.org/2001/XMLSchema#string

P932

4817814

http://www.w3.org/2001/XMLSchema#string